Page 7 of 10
Organic & Biomolecular Chemistry
Please do not adjust margins
Journal Name
ARTICLE
N-[(Azocan-1-yl)methyl]prop-2-enamide hydrochloride (7a.HCl). 6H), 4.03 (d, J 6.3 Hz, 2H), 5.30 (s, 1H), 5.66 (s, 1H), 6.31-6.45 (brs,
DOI: 10.1039/C8OB00811F
1
13
white solid; mp 87-89 °C (recryst. from EtOAc); H NMR (400 MHz, 1H); C NMR (101 MHz, CDCl3) δ 18.7, 42.3 (both Me), 62.2, 119.5
DMSO-d6) δ 1.43-1.70 (m, 6H), 1.76-1.96 (m, 4H), 3.10-3.16 (m, 2H), (all CH2), 140.1 (C), 169.0 (C=O); HRMS (ESI) m/z [M+H]+, C7H15N2O
3.22-3.32 (m, 2H), 4.48-4.68 (m, 2H), 5.69 (d, J 10.1 Hz, 1H), 6.25 (d, calcd 143.1184, observed 143.1180.
J 17.1 Hz, 1H), 6.43 (dd, J 10.1, 17.1 Hz, 1H), 9.58-9.67 (m, 1H, NH), N-[(Diethylamino)methyl]prop-2-enamide (9a). (32.39 g, 83%)
10.25-10.38 (brs, 1H, NH); 13C NMR (101 MHz, DMSO-d6) δ 22.1, yellow oil; bp 65-67 °C (0.25 mmHg); vmax (neat, cm-1) 3289, 2969,
24.0, 25.1, 48.8, 59.2, 128.2 (all CH2), 130.4 (CH), 166.2 (C=O).
2828, 1657 (C=O), 1624, 1536, 1464, 1233, 1206, 1067; 1H NMR
N-[(Azocan-1-yl)methyl]prop-2-enamide (7a). (5.30 g, 90%) (400 MHz, CDCl3) δ 1.08 (t, J 7.2 Hz, 6H), 2.56 (q, J 7.2 Hz, 4H), 4.29
colourless oil; vmax (neat, cm-1) 3328, 2917, 2850, 1657 (C=O), 1624, (d, J 6.1 Hz, 2H), 5.64 (dd, J 1.4, 10.2 Hz, 1H), 5.90-5.99 (brs, 1H),
1
1536, 1363, 1232, 1162, 1095, 1060; H NMR (400 MHz, CDCl3) δ 6.09 (dd, J 10.2, 17.0 Hz, 1H), 6.28 (dd, J 1.4, 17.0 Hz, 1H); 13C NMR
1.50-1.62 (m, 10H), 2.62-2.70 (m, 4H), 4.27 (d, J 6.0 Hz, 2H), 5.65 (d, (101 MHz, CDCl3) δ 12.7 (Me), 45.4, 56.9, 126.6 (all CH2), 131.0 (CH),
J 10.2 Hz, 1H), 5.91-6.02 (brs, 1H), 6.10 (dd, J 10.2, 17.0 Hz, 1H), 166.1 (C=O); HRMS (ESI) m/z [M+H]+, C8H17N2O, calcd. 157.1341,
6.28 (d, J 17.0 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 26.1, 27.7, 28.0, observed 157.1337.
51.6, 62.6, 126.7 (all CH2), 131.2 (CH), 166.0 (C=O); HRMS (ESI) m/z N-[(Diethylamino)methyl]-2-methylprop-2-enamide (9b). (33.21 g,
[M+H]+, C11H21N2O, calcd. 197.1656, observed 197.1654.
78%) colourless liquid, bp 72-74 °C (0.25 mmHg); vmax (neat, cm-1)
N-[(Azocan-1-yl)methyl]-2-methylprop-2-enamide hydrochloride 3344, 2970, 2827, 1656 (C=O), 1617, 1522, 1455, 1375, 1197, 1066,
(7b.HCl). white solid; mp 128-130 °C (recryst. from EtOAc); H NMR 1046; 1H NMR (400 MHz, CDCl3) δ 1.03 (t, J 7.2 Hz, 6H), 1.90 (s, 3H),
1
(400 MHz, DMSO-d6) δ 1.46-1.75 (m, 6H), 1.81-1.99 (m, 7H), 3.07- 2.52 (q, J 7.2 Hz, 4H), 4.22 (d, J 6.0 Hz, 2H), 5.27 (s, 1H), 5.63 (s, 1H),
3.18 (m, 2H), 3.23-3.35 (m, 2H), 4.45-4.53 (m, 2H), 5.70 (s, 1H), 5.93 6.11-6.21 (brs, 1H); 13C NMR (101 MHz, CDCl3) δ 12.7, 18.8 (both
(s, 1H), 9.17-9.27 (brs, 1H, NH), 9.94-10.09 (brs, 1H, NH); 13C NMR Me), 45.4, 57.3, 119.5 (all CH2), 140.2 (C), 168.9 (C=O); HRMS (ESI)
(101 MHz, DMSO-d6) δ 18.4 (Me), 22.2, 24.0, 25.0, 48.9, 59.8, 122.0 m/z [M+H]+, C9H19N2O calcd. 171.1497, observed 171.1789.
(all CH2), 138.4 (C), 168.6 (C=O).
N-[(Dipropylamino)methyl]prop-2-enamide (10a). (37.80 g, 82%)
N-[(Azocan-1-yl)methyl]-2-methylprop-2-enamide (7b). (5.30 g, colourless plates, mp 25-26 °C; vmax (neat, cm-1) 3269, 2959, 2930,
84%) colourless oil; vmax (neat, cm-1) (neat, cm-1) 3324, 2918, 2850, 1657 (C=O), 1623, 1550, 1457, 1246, 1185, 1069; 1H NMR (500 MHz,
1655, 1618 (C=O), 1523, 1452, 1363, 1201, 1162, 1095, 1060; 1H CDCl3) δ 0.82 (t, J 7.4 Hz, 6H), 1.44 (sext, J 7.4 Hz, 4H), 2.39 (t, J 7.4
NMR (400 MHz, CDCl3) δ 1.49-1.59 (m, 10H), 1.93 (s, 3H), 2.61-2.66 Hz, 4H), 4.23 (d, J 6.0 Hz, 2H), 5.58 (dd, J 1.6, 10.2 Hz, 1H), 6.11 (dd,
(m, 4H), 4.21 (t, J 4.3 Hz, 2H), 5.28 (s, 1H), 5.64 (s, 1H), 6.12-6.26 J 10.2, 17.0 Hz, 1H), 6.22 (dd, J 1.6, 17.0 Hz, 1H), 6.28-6.39 (brs, 1H);
(brs, 1H, NH); 13C NMR (101 MHz, CDCl3) δ 18.8 (Me), 26.0, 27.7, 13C NMR (125 MHz, CDCl3) δ 11.9 (Me), 20.9, 54.0, 58.1, 126.5 (all
28.0, 51.5, 62.7, 119.2 (all CH2), 140.4 (C), 168.9 (C=O); HRMS (ESI) CH2), 131.1 (CH DEPT up issue), 166.1 (C=O); HRMS (ESI) m/z
m/z [M+H]+, C12H23N2O, calcd. 211.1838, observed 211.1810.
[M+H]+, C10H21N2O calcd. 185.1654, observed 185.1663.
N-[(Dipropylamino)methyl]-2-methylprop-2-enamide (10b). (43.62
Synthesis of N-[(dialkylamino)methyl)]acrylamides and N-[(dialkyl- g, 88%) colourless liquid, bp 86-88 °C (0.25 mmHg); vmax (neat, cm-1)
amino)methyl)]methacrylamides
3316, 2959, 2934, 2873, 1655 (C=O), 1619, 1524, 1456, 1374, 1183,
1
A solution of acrylamide or methacrylamide (0.25 mol) in MeCN (50 1075, 1052; H NMR (400 MHz, CDCl3) δ 0.85 (t, J 7.4 Hz, 6H), 1.46
mL) was added to a stirred solution of freshly prepared Schiff base (sext, J 7.4 Hz, 4H), 1.93 (s, 3H), 2.42 (t, J 7.4 Hz, 4H), 4.22 (d, J 6.0
salt 4c-4f (0.25 mol) in MeCN (50 mL) and stirred at ca. 20 °C for 3 Hz, 2H), 5.29 (s, 1H), 5.65 (s, 1H), 6.02-6.15 (brs, 1H); 13C NMR (101
h. An aqueous solution of Na2CO3 (150 mL, 3M) was added and the MHz, CDCl3) δ 11.9, 18.8 (both Me), 20.9, 54.1, 58.5, 119.4 (all CH2),
solution stirred for an additional of 30 min and extracted with 140.3 (C), 168.9 (C=O); HRMS (ESI) m/z [M+H]+, C11H23N2O calcd.
MeCN (4 x 250 mL). The organic layer was dried (MgSO4), filtered 199.1810, observed 199.1800.
and evaporated to give the corresponding acrylamides 8a-11a and N-[(Dibutylamino)methyl]prop-2-enamide (11a). (44.56 g, 84%)
methacrylamides 8b-11b.
colourless liquid, bp 124-126 °C (0.25 mmHg); vmax (neat, cm-1)
3281, 3069, 2957, 2863, 1658 (C=O), 1625, 1542, 1456, 1459, 1366,
1
N,N-[(Dimethylamino)methyl]prop-2-enamide (8a). (22.11 g, 69%) 1180, 1071; H NMR (400 MHz, CDCl3) δ 0.89 (t, J 7.3 Hz, 6H), 1.24-
colourless liquid; bp 64-66 °C (760 mmHg); vmax (neat, cm-1) 3281, 1.33 (m, 4H), 1.40-1.47 (m, 4H), 2.45 (t, J 7.5 Hz, 4H), 4.26 (d, J 6.0
2942, 2827, 2780, 1659 (C=O), 1625, 1536, 1407, 1230, 1029; 1H Hz, 2H), 5.63 (dd, J 1.5, 10.2 Hz, 1H), 5.88-6.00 (brs, 1H), 6.10 (dd, J
NMR (400 MHz, CDCl3) δ 2.24 (s, 6H), 4.05 (d, J 6.4 Hz, 2H), 5.62 (dd, 10.2, 17.0 Hz, 1H), 6.27 (dd, J 1.5, 17.0 Hz, 1H); 13C NMR (101 MHz,
J 1.6, 10.2 Hz, 1H), 6.12 (dd, J 10.2, 17.0 Hz, 1H), 6.26 (dd, J 1.6, 17.0 CDCl3) δ 14.1 (Me), 20.7, 30.0, 51.9, 58.3, 126.7 (all CH2), 131.0
Hz, 1H), 6.71-6.82 (brs, 1H); 13C NMR (101 MHz, CDCl3) δ 41.8 (Me), (CH), 166.0 (C=O); HRMS (ESI) m/z [M+H]+, C12H25N2O calcd
61.5, 126.0 (both CH2), 130.7 (CH), 166.2 (C=O); HRMS (ESI) m/z 213.1967, observed 213.1952.
[M+H]+, C6H13N2O, calcd. 129.1028, observed 129.1026.
N-[(Dibutylamino)methyl]-2-methylprop-2-enamide (11b). (49.21
N,N-[(Dimethylamino)methyl]-2-methylprop-2-enamide
(8b). g, 87%) colourless liquid, bp 133-135 °C (0.25 mmHg); vmax (neat,
(32.10 g, 90%) colourless liquid, bp 60-62 °C (0.25 mmHg); vmax cm-1) 3325, 2957, 2931, 2872, 1625 (C=O), 1525, 1456, 1374, 1296,
(neat, cm-1) 3323, 2942, 2827, 1658 (C=O), 1619, 1523, 1453, 1311, 1179, 1083, 1034; 1H NMR (400 MHz, CDCl3) δ 0.89 (t, J 7.4 Hz, 6H),
1
1196, 1049, 1033; H NMR (400 MHz, CDCl3) δ 1.92 (s, 3H), 2.23 (s, 1.25-1.34 (m, 4H), 1.40-1.47 (m, 4H), 1.95 (s, 3H), 2.46 (t, J 7.4 Hz,
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 7
Please do not adjust margins